Zdjęcia: autora – Piotr Męcik, przypadków: ryc. 1 – archiwum prof. A. Andrzejewskiej z UMB, ryc. 2 – archiwum prywatne

Piśmiennictwo

1. Campbell GA, Hu D, Kusa MD. Acute kidney injury in the cancer patient. Adv Chronic Kidney Dis. 2014; 38:1786-8

2. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter 2012; 2(Suppl):1-138

3. Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol. Dial. Transplant. 2012; 27(12):4263-72

4. McDonald RJ, McDonald JS, Carter RE et al. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology. 2014; 273(3):714-25

5. Langham RG, Bellomo R, D’Intini V et al. KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for Acute Kidney Injury. Nephrology (Carlton) 2014; 19(5):261-5

6. Brar SS, Aharonian V, Mansukhani P et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014; 383(9931):1814-23

7. Anderson JL, Adams CD, Antman EM et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61(23):e179-347

8. Er F, Nia AM, Dopp H et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation. 2012; 126(3):296-303

9. McCafferty K, Byrne C, Yaqoob MM. Ischaemic conditioning strategies for the nephrologist: a promise lost in translation? Nephrol Dial Transplant. 2014; 29(10):1827-40

10. Abaci O, Arat Ozkan A, Kocas C et al. Impact of rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography. Am J Cardiol. 2015; 115(7):867-71

11. Peruzzi M, De Luca L, Thomsen HS et al. A network meta-analysis on randomized trials focusing on the preventive effect of statins on contrast-induced nephropathy. Biomed Res Int. 2014; 2014:213239

12. Markota D, Markota I, Starcevic B et al. Prevention of contrast-induced nephropathy with Na/K citrate. Eur Heart J. 2013; 34(30):2362-7

13. Sekiguchi H, Ajiro Y, Uchida Y et al. Oxygen pre-conditioning prevents contrast-induced nephropathy (OPtion CIN Study). J Am Coll Cardiol. 2013; 62(2):162-3

14. Rim MY, Ro H, Kang WC et al. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study. Am J Kidney Dis. 2012; 60(4):576-82

15. Cicin I, Erdogan B, Gulsen E et al. Incidence of contrast-induced nephropathy in hospitalised patients with cancer. Eur Radiol. 2014; 24(1):184-90

16. Mussap M, Merlini G. Pathogenesis of renal failure in multiple myeloma: any role of contrast media? Biomed Res Int. 2014; 2014:167125

17. Pahade JK, LeBedis CA, Raptopoulos VD et al. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. AJR Am J Roentgenol. 2011; 196(5):1094-101

18. Preda L, Agazzi A, Raimondi S et al. Effect on renal function of an iso-osmolar contrast agent in patients with monoclonal gammopathies. Eur Radiol. 2011; 21(1):63-9

19. Ng CS, Shaw AD, Bell CS, Samuels JA. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR Am J Roentgenol. 2010; 195(2):414-22